9
Views
1
CrossRef citations to date
0
Altmetric
Original Article

The Treatment of the Withdrawal Stage in Narcotic Addicts by Diphenoxylate and Chlormethiazole

Pages 593-596 | Published online: 03 Jul 2009

References

  • Fraser H. F., Isbell H. Human pharmacology and addictiveness of ethyl 1-(3-cyano-3, 3-phenylpropyl)-4-phenyl-4-piperidine carboxylate hydrochloride (R-1132, Diphenoxylate). Bull. Narcotics (U.N.) 1961; 13: 29–43
  • Chlormethiazole. Proceedings of a Symposium, E. P. Frisch. Munksgaard, Copenhagen 1966
  • Glatt M. M., George H. R., Frisch E. P. Evaluation of Chlormethiazole in Treatment for Alcohol Withdrawal Syndrome. Acta Psychiat. Scand. 1966; 42(Suppl. 192)121–137
  • Glatt M. M., Pittman D. J., Gillespie D. G., Hills D. R. The drug scene in Great Britain. Edward Arnold, London 1969, Revised Reprint
  • Glatt M. M. The alcoholic, and the help he needs. Priory Press, Royston, Herts 1970
  • Glatt M. M., Lewis D. M., Wilson D. T. An oral method of the withdrawal treatment of heroin dependence: A five years' study of a combination of diphenoxylate (Lomotil) and chlormethiazole (Heminevrin). Brit. J. Addictions 1970; 65: 237–243
  • Goodman A. Diphenoxylate hydrochloride in the withdrawal of narcotic addiction. Southern Med. J. 1968; 61: 313–316
  • WHO Expert-Committee on Addiction-Producing Drugs. 11th Report. World Health Organization Tech. Rep. Ser. 1961; 211: 5–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.